A carregar...
Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?
Lung cancer is still the leading cause of death among all cancers. During the last 15 years, pharmacogenomics of lung cancer have established targeted therapy with tyrosine kinase inhibitors (TKIs) for epidermal growth factor receptor (EGFR) positive patients in adenocarcinoma or mixed adenosquamus...
Na minha lista:
| Publicado no: | Clin Transl Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5243233/ https://ncbi.nlm.nih.gov/pubmed/28101783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-017-0135-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|